Why do patients still die from gestational trophoblastic neoplasia? System failures beyond curability
Antonio Braga, Sue Yazaki Sun, Edward Araujo, Jorge de Rezende-Filho · 2026
Read Why do patients still die from gestational trophoblastic neoplasia? System failures beyond curability by Antonio Braga, Sue Yazaki Sun, Edward Araujo, Jorge de Rezende-Filho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13524358.txt.
Description
Antonio Braga and three co-authors asked a hard question in 2026: why do patients still die from a cancer that doctors can usually cure? The cancer grows from placental tissue after pregnancy and spreads fast, yet chemo cures most cases. It was the first spread cancer cured by drugs. Half of cases follow a molar pregnancy, which doctors watch closely.
The other half follow normal births, miscarriages, or ectopic pregnancies, where no one expects cancer. Late detection is one system failure the authors name. The disease is rare, so most doctors never see a case. Care at expert centers saves lives, but distance from such centers can slow diagnosis and treatment.
Catalog record
| CREATOR | Antonio Braga, Sue Yazaki Sun, Edward Araujo, Jorge de Rezende-Filho |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |